Janus Henderson Group PLC Nuvalent, Inc. Transaction History

Janus Henderson Group PLC

$194 Billion
Q2 2025

A detailed history of Janus Henderson Group PLC transactions in Nuvalent, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 1,782,581 shares of NUVL stock, worth $137 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

1,782,581

Previous 1,310,196 36.05%

Holding current value

$137 Million

Previous $92.9 Million 46.37%

% of portfolio

0.07%

Previous 0.05%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$59.32 - $79.68 $28 Million - $37.6 Million	472,385 Added 36.05%	1,782,581 $136 Million
Q1 2025 May 15, 2025	BUY	$67.38 - $88.96 $87.2 Million - $115 Million	1,293,580 Added 7785.15%	1,310,196 $92.9 Million
Q4 2024 Feb 14, 2025	SELL	$77.87 - $104.93 $85,657 - $115,423	-1,100 Reduced 6.21%	16,616 $1.3 Million
Q3 2024 Nov 14, 2024	BUY	$67.44 - $112.17 $337,200 - $560,850	5,000 Added 39.32%	17,716 $1.81 Million
Q2 2024 Aug 14, 2024	SELL	$62.76 - $81.61 $8,409 - $10,935	-134 Reduced 1.04%	12,716 $964,000
Q1 2024 May 15, 2024	BUY	$72.35 - $88.99 $506 - $622	7 Added 0.05%	12,850 $964,000
Q4 2023 Feb 14, 2024	BUY	$42.42 - $80.28 $189,320 - $358,289	4,463 Added 53.26%	12,843 $945,000
Q3 2023 Nov 14, 2023	SELL	$39.12 - $49.85 $1.9 Million - $2.42 Million	-48,536 Reduced 85.28%	8,380 $385,000
Q2 2023 Aug 14, 2023	SELL	$23.58 - $44.68 $4.27 Million - $8.09 Million	-181,038 Reduced 76.08%	56,916 $2.4 Million
Q1 2023 May 15, 2023	SELL	$25.42 - $33.52 $138,818 - $183,052	-5,461 Reduced 2.24%	237,954 $6.21 Million
Q4 2022 Feb 14, 2023	SELL	$18.46 - $36.37 $2.87 Million - $5.65 Million	-155,241 Reduced 38.94%	243,415 $7.25 Million
Q3 2022 Nov 14, 2022	SELL	$13.55 - $19.92 $11.5 Million - $16.9 Million	-848,509 Reduced 68.04%	398,656 $7.75 Million
Q2 2022 Aug 15, 2022	SELL	$7.4 - $15.07 $667,924 - $1.36 Million	-90,260 Reduced 6.75%	1,247,165 $16.9 Million
Q1 2022 May 16, 2022	SELL	$11.65 - $19.57 $939,246 - $1.58 Million	-80,622 Reduced 5.69%	1,337,425 $18.6 Million
Q4 2021 Feb 14, 2022	SELL	$18.01 - $30.1 $178,821 - $298,862	-9,929 Reduced 0.7%	1,418,047 $26.1 Million
Q3 2021 Nov 16, 2021	BUY	$18.25 - $38.35 $26.1 Million - $54.8 Million	1,427,976 New	1,427,976 $30.2 Million

Others Institutions Holding NUVL

# of Institutions

226

Shares Held

59.5M

Call Options Held

277K

Put Options Held

255K

View Full List

About Nuvalent, Inc.

Ticker NUVL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,977,800
Market Cap $3.29B
Description
Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...

More about NUVL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Nuvalent, Inc. Transaction History